Louis M. Guzzi

Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference

Marlies Ostermann, Alexander Zarbock, Stuart L. Goldstein et al. · JAMA Network Open · 2020 · 647 citations · Full text

Medicine, Nephrology, Acute Care Medicine +14

A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients With Sepsis and Suspected Disseminated Intravascular Coagulation*

Jean‐Louis Vincent, M Ramesh, David Ernest et al. · Critical Care Medicine · 2013 · 322 citations

Medicine, Pharmacology, Pharmacotherapy +15

Controlled Resuscitation for Uncontrolled Hemorrhagic Shock

David Burris, Peter Rhee, Christoph Kaufmann et al. · 1999 · 169 citations

Medicine, Emergency Medicine, Hemodynamic Management +10

Clinical use of [TIMP-2]•[IGFBP7] biomarker testing to assess risk of acute kidney injury in critical care: guidance from an expert panel

Louis M. Guzzi, Tobias Bergler, Brian Binnall et al. · Critical Care · 2019 · 82 citations · Full text

Medicine, Nephrology, Perioperative Medicine +17

Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia

Louis M. Guzzi, David McCollum, Marcie J. Hursting · Journal of Thrombosis and Thrombolysis · 2006 · 49 citations

Medicine, Hematology, Pharmacology +14